
Zoetis Shareholders Pursue Securities Class Action With Lead Plaintiff Needed
Zoetis shareholders have until July 27, 2026 to apply as lead plaintiff in a federal securities lawsuit alleging the company concealed declining sales.
Read more →
Zoetis shareholders have until July 27, 2026 to apply as lead plaintiff in a federal securities lawsuit alleging the company concealed declining sales.
Read more →
A class action alleges acetaminophen makers withheld warnings about potential prenatal autism risks.
Read more →
The Suboxone dental injury claim allows users who experienced unexpected dental deterioration while taking the medication to seek compensation from the...
Read more →
Vivimed has agreed to pay $1.9 million to settle economic loss claims against consumers and insurers who purchased contaminated Losartan blood pressure...
Read more →
The Pradaxa internal bleeding class action settlement represents one of the largest pharmaceutical settlements related to anticoagulant medication risks.
Read more →
The OxyContin deceptive marketing class action settlement represents a historic $7.4 billion agreement approved by U.S.
Read more →
Risperdal, manufactured by Janssen Pharmaceuticals (a Johnson & Johnson subsidiary), was heavily marketed off-label to physicians treating elderly...
Read more →
The Vioxx Heart Attack Class Action Settlement represents one of the largest pharmaceutical settlements in U.S. history, with Merck agreeing to pay $4.
Read more →
Actos, a diabetes medication manufactured by Takeda Pharmaceuticals, was the subject of a $2.4 billion class action settlement that resolved thousands of...
Read more →
The Risperdal male breast growth gynecomastia class action represents one of the most significant pharmaceutical liability settlements involving Johnson &...
Read more →
The Xarelto internal bleeding class action settlement represents one of the largest pharmaceutical litigation resolutions in recent history, with Johnson...
Read more →
The Yaz and Yasmin birth control settlement represents one of the largest pharmaceutical class action settlements in U.S. history.
Read more →
The Essure permanent birth control system generated one of the largest medical device settlements in history: a 2020 class action settlement worth $1.
Read more →
The Seroquel XR $5.475 million pharmaceutical class action settlement represents a significant antitrust victory against AstraZeneca Pharmaceuticals LP,...
Read more →
The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers list, released on March 27, 2026, recognizes the nation's most accomplished advocates fighting...
Read more →
Ultragenyx Pharmaceutical investors who purchased shares between August 3, 2023 and December 26, 2025 have until April 6, 2026 to apply for lead plaintiff...
Read more →
Soleno Therapeutics, Inc. (NASDAQ: SLNO) is facing a major securities class action lawsuit brought by investors who claim the company systematically...
Read more →
Veeva Systems was sued by IQVIA for allegedly gaining unauthorized access to IQVIA's proprietary physician visit data and healthcare provider...
Read more →
Yes, 23andMe did attempt to sell its customers' genetic and medical data to pharmaceutical firms in the months before and after its Chapter 11...
Read more →
Cardinal Health, one of the largest pharmaceutical distributors in the United States, faces mounting legal consequences for shipping massive quantities of...
Read more →